Intervention Review

Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)

  1. G Mustafa Soomro1,*,
  2. Douglas G Altman2,
  3. Sundararajan Rajagopal3,
  4. Mark Oakley Browne4

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 11 NOV 2007

DOI: 10.1002/14651858.CD001765.pub3

How to Cite

Soomro GM, Altman DG, Rajagopal S, Oakley Browne M. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD001765. DOI: 10.1002/14651858.CD001765.pub3.

Author Information

  1. 1

    St. George's Hospital Medical School, Department of Psychiatry, London, UK

  2. 2

    Wolfson College Annexe, Centre for Statistics in Medicine, Oxford, UK

  3. 3

    South London and Maudsley NHS Trust, Adamson Centre for Mental Health, London, UK

  4. 4

    School of Rural Health , Department of Rural and Indigenous Health , PO Box 973 Moe , Victoria, Australia

*G Mustafa Soomro, Department of Psychiatry, St. George's Hospital Medical School, University of London, Cranmer Terrace, London, SW17 0RE, UK. gms357@hotmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >